ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

SN. Smith & Nephew Plc

982.60
-32.40 (-3.19%)
23 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Smith & Nephew Plc LSE:SN. London Ordinary Share GB0009223206 ORD USD0.20
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -32.40 -3.19% 982.60 984.60 985.00 1,010.50 981.00 1,010.50 4,001,268 16:35:05
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Ortho,prosth,surg Appl,suply 5.55B 263M 0.3011 32.71 8.6B
Smith & Nephew Plc is listed in the Ortho,prosth,surg Appl,suply sector of the London Stock Exchange with ticker SN.. The last closing price for Smith & Nephew was 1,015p. Over the last year, Smith & Nephew shares have traded in a share price range of 887.00p to 1,284.00p.

Smith & Nephew currently has 873,398,889 shares in issue. The market capitalisation of Smith & Nephew is £8.60 billion. Smith & Nephew has a price to earnings ratio (PE ratio) of 32.71.

Smith & Nephew Share Discussion Threads

Showing 1026 to 1049 of 1325 messages
Chat Pages: 53  52  51  50  49  48  47  46  45  44  43  42  Older
DateSubjectAuthorDiscuss
01/10/2021
11:17
Suet you are not the only one in this position!

When you see Myra Eskes Pres of APAC region selling a lot of stock you do wonder what they know that we don't. The results seemed ok and forward looking it seemed all ok.

Or is it just an II needing to raise cash? But I then expect an RNS about holdings every day.

gclark
01/10/2021
10:20
Increasing my holding here was not one of my better decisions!
This is a very unloved stock and Mr Market has shown no mercy.
As to the eventual low I hope it won't go sub £12 which is the level it reached when covid first became a major concern. Prior to covid we had been £19!!!!!!!!!!
Suet

suetballs
01/10/2021
09:15
Covid uncertainty strikes again-
New low for year.

How much more damage PLUS of course the pending arrival of the fly season will be infliced here.

Guesses as to eventual low?

pugugly
16/9/2021
11:32
Closed my trade for a few shekels, luck to holders.
essentialinvestor
16/9/2021
10:52
oversold imho
marcela9
15/9/2021
23:58
80% discounts in China, make it up in volume?
smcni1968
15/9/2021
16:50
Its in the UK, that's the problem!
ianood
15/9/2021
13:19
Stryker is not showing share price weakness so company specific would think.
essentialinvestor
14/9/2021
15:12
Had a small amount.
essentialinvestor
14/9/2021
11:52
OK Covid protective measures winding down but infections up though looking as though starting to go down but deaths starting to increase -However with restrictions coming off and winter coming very likley (imo)to be an acceration to the upside of both cases hospitalisations and deaths and therefore a decline in elective surgery BAD for SN.


Use above link if you wish to double check trends -

pugugly
14/9/2021
10:28
A little good news here would be more than welcome given the positive interims. Surely the Company has a fair indication of upswing now as Covid measures wind down. I think it would be prudent to issue an interim t/u in view of the continued share price erosion if only to stop the rot.
luzley
10/9/2021
11:26
I'll take £18 now please.
Suet

suetballs
10/9/2021
11:02
BARCLAYS CUTS SMITH & NEPHEW PRICE TARGET TO 1,800 (1,825) PENCE - 'OVERWEIGHT'
philanderer
24/8/2021
19:32
SP has bounced several times from the approx 13.75 type area.
Some type of support around there?, not holding atm.

essentialinvestor
24/8/2021
18:58
Today's RNS details shares issued partly in lieu of annual fees.


If you read yesterday's RNS, it's yet another director sale.

essentialinvestor
24/8/2021
18:47
What's going on with this share director buys big price goes down.
csalvage
16/8/2021
09:24
I expect we will get increasingly positive updates going forward as pent-up demand escalates and facilities reopen to clear backlogs. American healthcare consumers are not the most patient in the world.
luzley
16/8/2021
09:23
Affluent areas of US are facing much better - that's where most joint surgery is focused.
luzley
16/8/2021
08:25
Ok so no quick profits - but long term I am optimistic.
Suet

suetballs
16/8/2021
08:16
Thing is most of their business is in the us where things are getting worse
spoole5
13/8/2021
22:19
Looking to invest here, this seems like a great company with bags of potential for a Covid recovery play. Watching closely.
chard1980
12/8/2021
14:49
H2 guidance is predicated on normalisation of the COVID pandemic in their
major markets. Now currently we have the COVID situation in the US rapidly deteriorating-
hopefully that may peak within the next few weeks.


May be that is discounted at the current share price level, or someone else will see longer
term value and make an offer for the Company.


Ian, interesting re the epidural, these days they are far more cautious using GA.
Back in the day you were often put under general for even minor surgery.

essentialinvestor
12/8/2021
14:39
Keyno, you’re right.
I got fed up waiting for someone to
make some enlightened comment that would put some life into this board, hopefully I’ve done that.
Now make some comment on what I said about
+37% to +49% that’s constructive !

basildublin
12/8/2021
13:23
Basil has only been on ADVFN since yesterday.
keyno
Chat Pages: 53  52  51  50  49  48  47  46  45  44  43  42  Older

Your Recent History

Delayed Upgrade Clock